209 related articles for article (PubMed ID: 36627646)
1. Acute toxicities and cumulative dose to the brain of repeated sessions of stereotactic radiotherapy (SRT) for brain metastases: a retrospective study of 184 patients.
Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Thiery A; Cebula H; Noel G; Antoni D
Radiat Oncol; 2023 Jan; 18(1):7. PubMed ID: 36627646
[TBL] [Abstract][Full Text] [Related]
2. Radionecrosis after repeated courses of radiotherapy under stereotactic conditions for brain metastases: Analysis of clinical and dosimetric data from a retrospective cohort of 184 patients.
Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Cox DG; Bund C; Antoni D; Cebula H; Noel G
Cancer Radiother; 2022 Sep; 26(5):692-702. PubMed ID: 35715354
[TBL] [Abstract][Full Text] [Related]
3. Changes in the characteristics of patients treated for brain metastases with repeat stereotactic radiotherapy (SRT): a retrospective study of 184 patients.
Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Thiery A; Cebula H; Noel G; Antoni D
Radiat Oncol; 2023 Jan; 18(1):21. PubMed ID: 36717863
[TBL] [Abstract][Full Text] [Related]
4. Repeated Stereotactic Radiotherapy for Local Brain Metastases Failure or Distant Brain Recurrent: A Retrospective Study of 184 Patients.
Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Mazzara C; Cebula H; Noel G; Antoni D
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894315
[TBL] [Abstract][Full Text] [Related]
5. Local recurrence and cerebral progression-free survival after multiple sessions of stereotactic radiotherapy of brain metastases: a retrospective study of 184 patients : Statistical analysis.
Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Bund C; Chambrelant I; Antoni D; Noel G
Strahlenther Onkol; 2022 Jun; 198(6):527-536. PubMed ID: 35294567
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy plus stereotactic body radiation therapy or whole-brain radiation therapy in brain metastases.
Amin S; Baine M; Lin C
Immunotherapy; 2023 Feb; 15(3):163-174. PubMed ID: 36748364
[No Abstract] [Full Text] [Related]
7. Efficacy of salvage stereotactic radiotherapy (SRT) for locally recurrent brain metastases after initial SRT and characteristics of target population.
Holub K; Louvel G
Clin Transl Oncol; 2021 Jul; 23(7):1463-1473. PubMed ID: 33464481
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated Stereotactic Radiation Therapy to the Resection Bed for Intracranial Metastases.
Keller A; Doré M; Cebula H; Thillays F; Proust F; Darié I; Martin SA; Delpon G; Lefebvre F; Noël G; Antoni D
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1179-1189. PubMed ID: 28974415
[TBL] [Abstract][Full Text] [Related]
9. Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trial.
Zindler JD; Bruynzeel AME; Eekers DBP; Hurkmans CW; Swinnen A; Lambin P
BMC Cancer; 2017 Jul; 17(1):500. PubMed ID: 28743240
[TBL] [Abstract][Full Text] [Related]
10. Comparison of initial and sequential salvage brain-directed treatment in patients with 1-4 vs. 5-10 brain metastases from breast cancer (KROG 16-12).
Kim JS; Kim K; Jung W; Shin KH; Im SA; Kim HJ; Kim YB; Chang JS; Kim JH; Choi DH; Park YH; Kim DY; Kim TH; Choi BO; Lee SW; Kim S; Kwon J; Kang KM; Chung WK; Kim KS; Yoon WS; Kim JH; Cha J; Oh YK; Kim IA
Breast Cancer Res Treat; 2023 Jul; 200(1):37-45. PubMed ID: 37138198
[TBL] [Abstract][Full Text] [Related]
11. Surgical bed stereotactic radiotherapy of brain metastases: Clinical outcome and predictors of local and distant brain failure.
Mousli A; Bihin B; Gustin T; Koerts G; Mouchamps M; Daisne JF
Cancer Radiother; 2020 Jul; 24(4):298-305. PubMed ID: 32173270
[TBL] [Abstract][Full Text] [Related]
12. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
[TBL] [Abstract][Full Text] [Related]
13. Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases.
Do L; Pezner R; Radany E; Liu A; Staud C; Badie B
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):486-91. PubMed ID: 18922650
[TBL] [Abstract][Full Text] [Related]
14. Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity.
Fritz C; Borsky K; Stark LS; Tanadini-Lang S; Kroeze SGC; Krayenbühl J; Guckenberger M; Andratschke N
Front Oncol; 2018; 8():551. PubMed ID: 30524969
[No Abstract] [Full Text] [Related]
15. Real-world analysis of different intracranial radiation therapies in non-small cell lung cancer patients with 1-4 brain metastases.
Chen Z; Zhou L; Zhao M; Cao K; Li Y; Liu X; Hou Y; Li L; Wang L; Chang L; Yang M; Li W; Xia Y
BMC Cancer; 2022 Sep; 22(1):1010. PubMed ID: 36153515
[TBL] [Abstract][Full Text] [Related]
16. Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis.
Patel KR; Burri SH; Boselli D; Symanowski JT; Asher AL; Sumrall A; Fraser RW; Press RH; Zhong J; Cassidy RJ; Olson JJ; Curran WJ; Shu HG; Crocker IR; Prabhu RS
J Neurooncol; 2017 Feb; 131(3):611-618. PubMed ID: 28000105
[TBL] [Abstract][Full Text] [Related]
17. Application of a multi-institutional nomogram predicting salvage whole brain radiation-free survival to patients treated with postoperative stereotactic radiotherapy for brain metastases.
Mousli A; Bihin B; Gustin T; Koerts G; Mouchamps M; Daisne JF
Cancer Radiother; 2021 Apr; 25(2):141-146. PubMed ID: 33422416
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.
Karlovits BJ; Quigley MR; Karlovits SM; Miller L; Johnson M; Gayou O; Fuhrer R
Neurosurg Focus; 2009 Dec; 27(6):E7. PubMed ID: 19951060
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and limitations of stereotactic radiosurgery as a salvage treatment after failed whole brain radiotherapy for brain metastases.
Yomo S; Hayashi M
J Neurooncol; 2013 Jul; 113(3):459-65. PubMed ID: 23661101
[TBL] [Abstract][Full Text] [Related]
20. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
